Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Evidence of Educational Bias in Cognitive Screening of Adults with Sickle Cell Disease: Comparison of Available Tools and Possible Strategies for Mitigation

Stéphanie Forté, MD MSc, FRCPC, Maryline Couette, PhD, Damien Oudin Doglioni, PhD, Denis Soulieres, MD, Kevin H.M. Kuo, MDMSc,FRCPC, Pablo Bartolucci, MD PhD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-143169

Published: 2020

Journal Articles

Validation of a Predictive Score of Acute Chest Syndrome (presev-2 study) in Adults

Christian Kassasseya, MD, Kene Sekou, MD, Tatiana Besse-Hammer, MD, Ruben Nzouakou, MD, Jean-Benoît Arlet, MD, Jean Magnang, MD, Louis Affo, MD, Sandrine Dautheville, MD, Stéphanie Ngo, MD, Mehdi Khellaf, MD PhD, Dapa Aly Diallo, MD PhD, Pablo Bartolucci, MD PhD

Blood (2020) 136 (Supplement 1): 23.

https://doi.org/10.1182/blood-2020-143035

Published: 2020

Journal Articles

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic

Gonzalo De Luna, Nicolas Lemonier, MD, Alexis Aidan, MD, Lea Bontemps, MD, Manuel Hautefaye, MD, Hadrien Diakonoff, MD, Cecile Aubrun, Anne-Laure Pham Hung D'Alexandry D'Orengiani, PhD, Dora Bachir, MD, Françoise Driss, MD, Amna Jebali, MD, Anoosha Habibi, MD PhD, Pablo Bartolucci, MD PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142796

Published: 2020

Journal Articles

Outcome of Severe Vaso-Occlusive Crisis in Sickle Cell Disease Adults Admitted to Referral Centers in Africa and Europe. Introduction of Machine Learning Methods to Improve the Presev Score

Yamna Ouchtar, Christian Kassasseya, MD, Kene Sekou, MD, Anne-Laure Pham Hung D'Alexandry D'Orengiani, PhD, Mehdi Kellaf, MD PhD, Dapa Aly Diallo, MD PhD, Laurent Najman, PhD, Pablo Bartolucci, MD PhD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-143059

Published: 2020

Journal Articles

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Erica B. Esrick, MD, Maureen Achebe, MD MPH, Myriam Armant, PhD, Pablo Bartolucci, MD PhD, Marioara Felicia Ciuculescu, MD, Heather Daley, Colleen Dansereau, MSN, RN, CPN, Giuseppe Di Caprio, PhD, Bronner Goncalves, MD PhD, Nicolas Hebert, Matthew M Heeney, MD, John M. Higgins, MD PhD, Leslie E. Lehmann, MD, John P Manis, MD, Olivier Negre, PhD, Sarah Nikiforow, MD PhD, Ethan Schonbrun, PhD, David K. Wood, PhD, David A. Williams, MD

Blood (2019) 134 (Supplement_2): LBA-5.

https://doi.org/10.1182/blood-2019-132745

Published: 2019

Journal Articles

Rituximab for Preventing Delayed Hemolytic Transfusion Reaction (DHTR) in Sickle CELL Adult Patients: Outcome of Transfusion and SIDE Effects in 58 CASES

Fabian Zanchetta-Balint, France Pirenne, MD PhD, Marc Michel, Armand Mekontso-Dessap, MD PhD, Matthieu Mahevas, MD, Constance Guillaud, MD, Keyvan Razazi, MD, Elena Foïs, MD, Frédéric Galactéros, MD PhD, Pablo Bartolucci, MD PhD, Anoosha Habibi

Blood (2019) 134 (Supplement_1): 3687.

https://doi.org/10.1182/blood-2019-130874

Published: 2019

Journal Articles

Development of a Personalized 3D Carotid Model for Cerebral Vasculopathy Monitoring in Sickle Cell Disease

Nguyen-Peyre Kim-Anh, PhD, Laurène Lenoir, Valentin Amar, Frédéric Segonds, Nuriye Akçay, Seguin Marion, Philippe Connes, PhD, France Pirenne, MD PhD, Jean-Frédéric Gerbeau, Irène Vignon-Clémentel, Suzanne Verlhac, MD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 3570.

https://doi.org/10.1182/blood-2019-124327

Published: 2019

Journal Articles

The Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomized, Multicenter, Open-Label, Phase II Study (STEADFAST)

Kenneth I. Ataga, MD, Santosh L. Saraf, MD, Vimal K. Derebail, MD, Claire C. Sharpe, Adlette Inati, MD, Jeffrey D. Lebensburger, DO, MSPH, Laurie DeBonnett, MD, Shirong Zhang, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1018.

https://doi.org/10.1182/blood-2019-124823

Published: 2019

Journal Articles

Outcomes of Pregnancies in Patients with Sickle-Cell Disease : Update from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Frédéric Galactéros, MD PhD, Giovanna Cannas, MD, Pablo Bartolucci, MD PhD, Ersi Voskaridou, Laure Joseph, MD, Emmanuelle Bernit, MD, Justine Gellen-Dautremer, MD, Corinne Charneau, MD, Stephanie Ngo, MD, Anoosha Habibi

Blood (2019) 134 (Supplement_1): 891.

https://doi.org/10.1182/blood-2019-125812

Published: 2019

Journal Articles

Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy

Blood (2019) 134 (Supplement_1): 3358.

https://doi.org/10.1182/blood-2019-127393

Published: 2019

Journal Articles

Treatment of Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease Patients By an Anti-C5 Antibody

Blood (2019) 134 (Supplement_1): 2458.

https://doi.org/10.1182/blood-2019-127176

Published: 2019

Journal Articles

Interest of a New Method for Free Plasma Heme Related Species Dosages in Sickle Cell Disease and Beta Thalassemia

Laurent Kiger, Sandia Adypagavane, Laura Bencheikh, PhD, Nicolas Hebert, Stephane Moutereau, MD, Frédéric Galactéros, MD PhD, Michael Marden, PhD, Yves Beuzard, MD, France Pirenne, MD PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 3381.

https://doi.org/10.1182/blood-2019-130600

Published: 2019

Journal Articles

Causes of Death in 198 Sickle Cell Adult Patients: Old and New Trends

Anoosha Habibi, Stephanie Ngo, MD, Etienne Audureau, MD PhD, Armand Mekontso-Dessap, MD PhD, Keyvan Razazi, MD, Elena Foïs, MD, Thibaud Damy, MD PhD, France Pirenne, MD PhD, Marc Michel, Vincent Audard, MD PhD, Frédéric Galactéros, MD PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1031.

https://doi.org/10.1182/blood-2019-131304

Published: 2019

Journal Articles

Fetal Hemoglobin Measurement per Red Blood Cell Provides Biological and Clinical Protective Thresholds

Nicolas Hebert, Rakotoson Marie Georgine, PhD, Gwellaouen Bodivit, Etienne Audureau, MD PhD, Nadia Oubaya, Sadaf Pakdaman, Mehdi Sakka, Gaetana Di Liberto, PhD, Philippe Chadebech, PhD, Benoît Vingert, PhD, France Pirenne, MD PhD, Frédéric Galactéros, MD PhD, Marie Cambot, PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1008.

https://doi.org/10.1182/blood-2019-126727

Published: 2019

Journal Articles

Protective Effects of Carbon Monoxide Delivered By Corm-401 in Hyperhemolysis in Patients with Sickle Cell Disease

Nguyen-Peyre Kim-Anh, PhD, Bodivit Gwellaouen, Foresti Roberta, PhD, Kiger Laurent, PhD, Gaetana Di Liberto, PhD, Philippe Chadebech, PhD, Alicia Jouard, Sadaf Pakdaman, Seguin Marion, Marden Micheal, PhD, France Pirenne, MD PhD, Motterlini Roberto, PhD, Pablo Bartolucci, MD PhD

Blood (2018) 132 (Supplement 1): 2367.

https://doi.org/10.1182/blood-2018-99-112900

Published: 2018

Journal Articles

Study of Metabolic Acidosis in Sickle Cell Disease Patients

Maud Cazenave, MD, Vincent Audard, MDPhD, Jean-Philippe Bertocchio, MDPhD, Anoosha Habibi, Caroline Bertoye, MD, Thomas Stehle, MD, Jugurtha Berkenou, Frédéric Galactéros, MD PhD, Pascal Houillier, Pablo Bartolucci, MD PhD, Marie Courbebaisse, MD PhD

Blood (2018) 132 (Supplement 1): 3667.

https://doi.org/10.1182/blood-2018-99-110235

Published: 2018

Journal Articles

Predictive Factors for Survival in Sickle Cell Disease: A Cohort Study Using Etendard Data

Laurent Savale, MD PhD, Gylna Loko, MD, François Lionnet, Bernard Maitre, Anoosha Habibi, Jocelyn Inamo, Dora Bachir, MD, Françoise Driss, Vincent Audard, MDPhD, Etienne Audureau, Marc Humbert, Gerald Simonneau, Frédéric Galactéros, MDPhD, Florence Parent, Pablo Bartolucci, MD PhD

Blood (2018) 132 (Supplement 1): 7.

https://doi.org/10.1182/blood-2018-99-113767

Published: 2018

Journal Articles

Analysis of RBC Properties in Patients with SCD Treated with Lentiglobin Gene Therapy

Nicolas Hebert, Elisa Magrin, PhD, Annarita Miccio, PhD, Kiger Laurent, PhD, Nguyen-Peyre Kim-Anh, PhD, Laure Joseph, MD, Alessandra Magnani, MD PhD, Chloé Couzin, MD, Wassim El Nemer, PhD, France Pirenne, MD PhD, Olivier Negre, PhD, Jean-Antoine Ribeil, MD PhD, Isabelle André-Schmutz, PhD, Pablo Bartolucci, MD PhD, Marina Cavazzana, MD PhD

Blood (2018) 132 (Supplement 1): 2195.

https://doi.org/10.1182/blood-2018-99-115973

Published: 2018

Journal Articles

Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy

Blood (2017) 130 (Supplement 1): 4609.

https://doi.org/10.1182/blood.V130.Suppl_1.4609.4609

Published: 2017

Journal Articles

Prospective Controlled Trial on Endurance Exercise Training in Adult Sickle Cell Disease Patients

Barnabas Gellen, Laurent Messonnier, Angele Merlet, Etienne Audureau, Thomas Rupp, Sandrine Peyrot, Cyril Martin, PhD, Jean-Antoine Ribeil, MD PhD, jean Benoit Arlet, Frédéric Galactéros, MDPhD, Leonard Feasson, Pablo Bartolucci, MD PhD

Blood (2017) 130 (Supplement 1): 991.

https://doi.org/10.1182/blood.V130.Suppl_1.991.991

Published: 2017

NARROW

Evidence of Educational Bias in Cognitive Screening of Adults with Sickle Cell Disease: Comparison of Available Tools and Possible Strategies for Mitigation

Validation of a Predictive Score of Acute Chest Syndrome (presev-2 study) in Adults

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic

Outcome of Severe Vaso-Occlusive Crisis in Sickle Cell Disease Adults Admitted to Referral Centers in Africa and Europe. Introduction of Machine Learning Methods to Improve the Presev Score

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Rituximab for Preventing Delayed Hemolytic Transfusion Reaction (DHTR) in Sickle CELL Adult Patients: Outcome of Transfusion and SIDE Effects in 58 CASES

Development of a Personalized 3D Carotid Model for Cerebral Vasculopathy Monitoring in Sickle Cell Disease

The Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomized, Multicenter, Open-Label, Phase II Study (STEADFAST)

Outcomes of Pregnancies in Patients with Sickle-Cell Disease : Update from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy

Treatment of Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease Patients By an Anti-C5 Antibody

Interest of a New Method for Free Plasma Heme Related Species Dosages in Sickle Cell Disease and Beta Thalassemia

Causes of Death in 198 Sickle Cell Adult Patients: Old and New Trends

Fetal Hemoglobin Measurement per Red Blood Cell Provides Biological and Clinical Protective Thresholds

Protective Effects of Carbon Monoxide Delivered By Corm-401 in Hyperhemolysis in Patients with Sickle Cell Disease

Study of Metabolic Acidosis in Sickle Cell Disease Patients

Predictive Factors for Survival in Sickle Cell Disease: A Cohort Study Using Etendard Data

Analysis of RBC Properties in Patients with SCD Treated with Lentiglobin Gene Therapy

Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy

Prospective Controlled Trial on Endurance Exercise Training in Adult Sickle Cell Disease Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only